Why AI Chatbots Have Trouble Detecting Rare Mental Health Conditions Such As Intermittent Explosive Disorder

AI chatbots are proving dangerously inadequate at diagnosing rare mental health conditions like Intermittent Explosive Disorder (IED), a new analysis reveals. This shortcoming stems from training data overwhelmingly dominated by common disorders such as depression and anxiety, leaving thousands of patients misdiagnosed or untreated.

Forbes contributor Lance Eliot reports that AI chatbots — including popular platforms like ChatGPT, Gemini, and Claude — are increasingly used by individuals seeking mental health advice. However, these systems are optimized for high-frequency conditions. When a user describes symptoms of a rare disorder like IED — characterized by sudden outbursts of aggression and rage — the AI often defaults to more familiar categories, such as generalized anxiety or bipolar disorder. This can delay correct diagnosis for months or years.

The problem is deeply rooted in machine learning fundamentals. AI models are trained on vast datasets scraped from the internet, clinical notes, and medical literature. Rare conditions appear far less frequently, so the AI has fewer examples to learn from. A model might encounter 10,000 instances of depression for every one instance of IED. As a result, the AI's pattern-recognition algorithms are biased toward common diagnoses. The article emphasizes that this is not a bug but a feature of statistical learning: models naturally prioritize the most probable explanation.

Intermittent Explosive Disorder affects an estimated 1.4% to 7% of the U.S. population, but it remains widely underdiagnosed. Symptoms include recurrent, impulsive aggressive outbursts disproportionate to provocation. Experts quoted in the article worry that relying on AI chatbots for mental health triage could worsen this already low detection rate. The issue is compounded by the fact that many people feel more comfortable talking to a chatbot than a human therapist, potentially leading to false reassurance.

The Forbes analysis also highlights ongoing efforts to mitigate this bias. Techniques include synthetic data generation — creating realistic examples of rare conditions to train on — and few-shot learning, where models are given a handful of examples. Yet these approaches remain experimental. Major AI companies have not publicly committed to equipping their chatbots with comprehensive rare-disease knowledge. In the meantime, researchers urge users to treat AI mental health advice with extreme caution and always consult a human professional.

Looking ahead, regulators are starting to take notice. The U.S. Food and Drug Administration has not yet approved any AI chatbot for direct mental health diagnosis, but the lines are blurring. As generative AI becomes embedded in health apps and insurance portals, the risk of systematic misdiagnosis grows. Expect advocacy groups to push for transparency requirements — forcing AI makers to disclose which conditions their models can and cannot reliably detect. For now, anyone using an AI for mental health support should do so only as a first step, not a final answer.